FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...